ISIN | LU0804734431 |
---|---|
Valor Number | 18994882 |
Bloomberg Global ID | UHUSIA1 LX |
Fund Name | UBS (Lux) Equity SICAV - Global High Dividend Sustainable (USD) I-A1-acc |
Fund Provider |
UBS Asset Management Switzerland AG, Zurich
8098 Zürich, Schweiz E-Mail: ubs-am-wholesale-switzerland@ubs.com Web: www.ubs.com/fonds |
Fund Provider | UBS Asset Management Switzerland AG, Zurich |
Representative in Switzerland |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
Distributor(s) |
UBS Global Asset Management Basel Phone: +41 61 288 20 20 |
Asset Class | Equities |
EFC Category | Equity Global Advanced Markets |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | UBS Asset Management categorises this sub-fund as a Sustainability Focus Fund. This sub-fund promotes environmental and/or social characteristics and complies with Article 8 of Regulation (EU) 2019/2088 on sustainability-related disclosures in the financial services sector (“SFDR”). This actively managed sub-fund invests worldwide following the principle of risk diversification, with at least two thirds of its assets invested in equities or other equity interests of small, medium and large-cap companies in both developed and emerging markets. The Fund strategy is to select companies with high, consistent dividends. As the sub-fund invests in many foreign currencies due to its global orientation, the portfolio or parts thereof may be hedged against the reference currency of the sub-fund in order to reduce the associated foreign currency risks. |
Peculiarities |
Current Price * | 278.53 USD | 07.03.2025 |
---|---|---|
Previous Price * | 276.86 USD | 06.03.2025 |
52 Week High * | 280.99 USD | 18.10.2024 |
52 Week Low * | 244.27 USD | 17.04.2024 |
NAV * | 278.53 USD | 07.03.2025 |
Issue Price * | 278.53 USD | 07.03.2025 |
Redemption Price * | 278.53 USD | 07.03.2025 |
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 938,107,664 | |
Unit/Share Assets *** | 17,139,619 | |
Trading Information SIX |
YTD Performance | +2.80% |
31.12.2024 - 07.03.2025
31.12.2024 07.03.2025 |
---|---|---|
YTD Performance (in CHF) | -0.30% |
31.12.2024 - 07.03.2025
31.12.2024 07.03.2025 |
1 month | +1.06% |
07.02.2025 - 07.03.2025
07.02.2025 07.03.2025 |
3 months | +0.53% |
09.12.2024 - 07.03.2025
09.12.2024 07.03.2025 |
6 months | +4.92% |
09.09.2024 - 07.03.2025
09.09.2024 07.03.2025 |
1 year | +12.41% |
07.03.2024 - 07.03.2025
07.03.2024 07.03.2025 |
2 years | +30.06% |
07.03.2023 - 07.03.2025
07.03.2023 07.03.2025 |
3 years | +34.69% |
07.03.2022 - 07.03.2025
07.03.2022 07.03.2025 |
5 years | +79.10% |
09.03.2020 - 07.03.2025
09.03.2020 07.03.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | 19.86 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date | 07.03.2025 |
Abbott Laboratories | 1.13% | |
---|---|---|
International Business Machines Corp | 1.12% | |
Novartis AG Registered Shares | 1.07% | |
Accenture PLC Class A | 1.07% | |
AbbVie Inc | 1.06% | |
Welltower Inc | 1.05% | |
Best Buy Co Inc | 1.05% | |
Gilead Sciences Inc | 1.05% | |
MediaTek Inc | 1.05% | |
Bristol-Myers Squibb Co | 1.05% | |
Last data update | 31.01.2025 |
TER | 0.67% |
---|---|
TER date | 31.05.2024 |
Performance Fee *** | 0.00% |
PTR | |
Max. Management Fee *** | 0.51% |
Ongoing Charges *** | 0.67% |
SRRI ***
|
|
SRRI date *** | 28.02.2025 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |